Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sample size computations for PK/PD population models.

Dongwoo Kang1, Janice B Schwartz, Davide Verotta

  • 1Department of Biopharmaceutical Sciences, University of California at San Francisco, 521 Parnassus Avenue, Box 0446, San Francisco, CA 94143-0446, USA.

Journal of Pharmacokinetics and Pharmacodynamics
|November 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of Clinical Trial Participation Among Older U.S. Adults With Multimorbidity: A Cross-Sectional Survey.

Clinical and translational science·2026
Same author

Role of defect-rich architectures in CO<sub>2</sub> capture ability of upcycled railway tie biochar.

Journal of environmental management·2026
Same author

Association between dental implantation and dementia: a nationwide population-based study.

BMC geriatrics·2026
Same author

Prevalence and Risk Factors of Deep Spinal Infection after Single-shot Epidural Injections: A Nationwide Cohort Study of 3.8 Million Pain Outpatients.

Anesthesiology·2026
Same author

Impact of gastrectomy on the risk of alcohol-associated liver disease in patients with gastric cancer.

Scientific reports·2026
Same author

Gastrointestinal Diagnostic Coding After Spinal Cord Injury: Health Behavior Correlates and Implications for Neurogenic Bowel Management in a Nationwide Claim-Based Cohort.

Journal of clinical medicine·2026
Same journal

Optimizing Subcutaneous Antibody Dosing Regimens Through Operating Space Maps: rHuPH20 Case Study.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Mechanistic modeling of FcRn-dependent IgG drug interactions: Clinical applications and dosing implications.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Comparing heavy-tailed residual error models for outlier handling in population PK modeling.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Personalized prophylactic therapy optimization in hemophilia A using a hybrid PK-PD-TTE model and deep RL.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Pediatric oral cavity physiologically based pharmacokinetic model to predict pharmacokinetics of mucoadhesive atropine gel to treat sialorrhea.

Journal of pharmacokinetics and pharmacodynamics·2026
Same journal

Exposure-safety analyses of talazoparib in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) in the TALAPRO-2 trial.

Journal of pharmacokinetics and pharmacodynamics·2026
See all related articles

This study presents a fast and accurate method for calculating sample sizes in population pharmacokinetic/pharmacodynamic (PK/PD) studies. The new approach enhances hypothesis testing efficiency and reduces patient numbers needed in clinical trials.

Area of Science:

  • Pharmacometrics
  • Clinical Trial Design
  • Statistical Modeling

Background:

  • Population pharmacokinetic/pharmacodynamic (PK/PD) studies are crucial for drug development.
  • Accurate sample size determination is essential for efficient hypothesis testing in these studies.
  • Current simulation-based methods for sample size computation can be time-consuming.

Purpose of the Study:

  • To develop a simple, fast, and accurate sample size computation method for hypothesis testing in population PK/PD studies.
  • To extend existing sample size calculation methods for repeated measurement experiments.
  • To evaluate the impact of different sampling strategies on required sample size.

Main Methods:

  • Utilized a first-order approximation of nonlinear mixed-effects models.

Related Experiment Videos

  • Employed a chi-square distributed Wald statistic for sample size calculation.
  • Extended Rochon's sample size computation method.
  • Performed Monte Carlo simulations to validate the method and assess sampling strategies (minimal vs. intensive).

    • Main Results:

    • The proposed method accurately computes minimum sample sizes to achieve desired statistical power for hypothesis testing.
    • Sample sizes were computed for various PK and PK/PD models under different conditions.
    • Intensive sampling strategies were shown to reduce the number of patients required in clinical studies.
    • The method provides significant time savings compared to existing simulation-based approaches.

    Conclusions:

    • The developed method offers a rapid and efficient approach for sample size computation in population PK/PD studies using nonlinear mixed-effects models.
    • The method is general and applicable to various hierarchical models.
    • Intensive sampling is a key factor in optimizing patient enrollment for clinical studies.